Your browser doesn't support javascript.
loading
53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.
Hong, Ruoxi; Ma, Fei; Zhang, Weimin; Yu, Xiying; Li, Qing; Luo, Yang; Zhu, Changjun; Jiang, Wei; Xu, Binghe.
Afiliación
  • Hong R; Department of Medical Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Ma F; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang W; Department of Medical Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Yu X; State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Li Q; State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Luo Y; Department of Medical Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Zhu C; Department of Medical Oncology, Cancer Institute and Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
  • Jiang W; College of Life Science/Tianjin Key Laboratory of Cyto-Genetical and Molecular Regulation, Tianjin Normal University, Tianjin, 300387, China.
  • Xu B; State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. wjiang6138@cicams.ac.cn.
BMC Cancer ; 16(1): 725, 2016 09 09.
Article en En | MEDLINE | ID: mdl-27613518

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pironas / Neoplasias de la Mama / Morfolinas / Resistencia a Antineoplásicos / Proteínas de la Ataxia Telangiectasia Mutada / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Proteína 1 de Unión al Supresor Tumoral P53 Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pironas / Neoplasias de la Mama / Morfolinas / Resistencia a Antineoplásicos / Proteínas de la Ataxia Telangiectasia Mutada / Inhibidores de Poli(ADP-Ribosa) Polimerasas / Proteína 1 de Unión al Supresor Tumoral P53 Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: China